BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36686791)

  • 1. Correlation between lung cancer probability and number of pulmonary nodules in baseline computed tomography lung cancer screening: A retrospective study based on the Chinese population.
    Wu Q; Zhao S; Huang Y; Wang J; Tang W; Zhou L; Qi L; Zhang Z; Xie Y; Zhang J; Li H; Wu N
    Front Oncol; 2022; 12():1061242. PubMed ID: 36686791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a deep learning-based lung nodule detection system as an alternative reader in a Chinese lung cancer screening program.
    Cui X; Zheng S; Heuvelmans MA; Du Y; Sidorenkov G; Fan S; Li Y; Xie Y; Zhu Z; Dorrius MD; Zhao Y; Veldhuis RNJ; de Bock GH; Oudkerk M; van Ooijen PMA; Vliegenthart R; Ye Z
    Eur J Radiol; 2022 Jan; 146():110068. PubMed ID: 34871936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.
    Walter JE; Heuvelmans MA; Yousaf-Khan U; Dorrius MD; Thunnissen E; Schermann A; Groen HJM; van der Aalst CM; Nackaerts K; Vliegenthart R; de Koning HJ; Oudkerk M
    J Thorac Oncol; 2018 Sep; 13(9):1410-1414. PubMed ID: 29775805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of low-dose computed tomography screening for lung cancer in asymptomatic participants.
    Deng Y; Xiong Z; Mao X; Zhou L; Guo F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):244-251. PubMed ID: 35545415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasculature surrounding a nodule: A novel lung cancer biomarker.
    Wang X; Leader JK; Wang R; Wilson D; Herman J; Yuan JM; Pu J
    Lung Cancer; 2017 Dec; 114():38-43. PubMed ID: 29173763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcentimeter lung nodules stable for 2 years at LDCT: long-term follow-up using volumetry.
    Shin KE; Lee KS; Yi CA; Chung MJ; Shin MH; Choi YH
    Respirology; 2014 Aug; 19(6):921-8. PubMed ID: 24934105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outstanding negative prediction performance of solid pulmonary nodule volume AI for ultra-LDCT baseline lung cancer screening risk stratification.
    Lancaster HL; Zheng S; Aleshina OO; Yu D; Yu Chernina V; Heuvelmans MA; de Bock GH; Dorrius MD; Gratama JW; Morozov SP; Gombolevskiy VA; Silva M; Yi J; Oudkerk M
    Lung Cancer; 2022 Mar; 165():133-140. PubMed ID: 35123156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
    Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
    Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Patient With a Pulmonary Nodule: A Review.
    Mazzone PJ; Lam L
    JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The volume and mass growth of persisted pulmonary nodules detected in low-dose CT screening and its influence factors].
    Sun Q; Huang Y; Zhao SJ; Zhang L; Tang W; Jin YJ; Wu N
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):274-279. PubMed ID: 29730914
    [No Abstract]   [Full Text] [Related]  

  • 18. Applying CT texture analysis to determine the prognostic value of subsolid nodules detected during low-dose CT screening.
    Sun Q; Huang Y; Wang J; Zhao S; Zhang L; Tang W; Wu N
    Clin Radiol; 2019 Jan; 74(1):59-66. PubMed ID: 30501892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
    Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
    Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds.
    Henschke CI; Yip R; Smith JP; Wolf AS; Flores RM; Liang M; Salvatore MM; Liu Y; Xu DM; Yankelevitz DF;
    AJR Am J Roentgenol; 2016 Dec; 207(6):1176-1184. PubMed ID: 27726410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.